Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34


Genetic variation in genes for the xenobiotic-metabolizing enzymes CYP1A1, EPHX1, GSTM1, GSTT1, and GSTP1 and susceptibility to colorectal cancer in Lynch syndrome.

Pande M, Amos CI, Osterwisch DR, Chen J, Lynch PM, Broaddus R, Frazier ML.

Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2393-401. doi: 10.1158/1055-9965.EPI-08-0326.


Immortal time bias in pharmaco-epidemiology.

Suissa S.

Am J Epidemiol. 2008 Feb 15;167(4):492-9. Epub 2007 Dec 3. Review.


Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer.

Newcomb PA, Baron J, Cotterchio M, Gallinger S, Grove J, Haile R, Hall D, Hopper JL, Jass J, Le Marchand L, Limburg P, Lindor N, Potter JD, Templeton AS, Thibodeau S, Seminara D; Colon Cancer Family Registry.

Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2331-43. Epub 2007 Nov 2.


Smoking and risk of breast cancer in carriers of mutations in BRCA1 or BRCA2 aged less than 50 years.

Breast Cancer Family Registry; Kathleen Cuningham Consortium for Research into Familial Breast Cancer (Australasia); Ontario Cancer Genetics Network (Canada).

Breast Cancer Res Treat. 2008 May;109(1):67-75. Epub 2007 Oct 31.


Environmental factors and colorectal tumor risk in individuals with hereditary nonpolyposis colorectal cancer.

Diergaarde B, Braam H, Vasen HF, Nagengast FM, van Muijen GN, Kok FJ, Kampman E.

Clin Gastroenterol Hepatol. 2007 Jun;5(6):736-42.


Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer.

Samowitz WS, Albertsen H, Sweeney C, Herrick J, Caan BJ, Anderson KE, Wolff RK, Slattery ML.

J Natl Cancer Inst. 2006 Dec 6;98(23):1731-8.


Cancer risks for mismatch repair gene mutation carriers: a population-based early onset case-family study.

Jenkins MA, Baglietto L, Dowty JG, Van Vliet CM, Smith L, Mead LJ, Macrae FA, St John DJ, Jass JR, Giles GG, Hopper JL, Southey MC.

Clin Gastroenterol Hepatol. 2006 Apr;4(4):489-98.


Cigarette smoking among adults--United States, 2004.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2005 Nov 11;54(44):1121-4.


Influence of selected lifestyle factors on breast and ovarian cancer risk in BRCA1 mutation carriers from Poland.

Gronwald J, Byrski T, Huzarski T, Cybulski C, Sun P, Tulman A, Narod SA, Lubinski J.

Breast Cancer Res Treat. 2006 Jan;95(2):105-9.


The joint effect of smoking and AIB1 on breast cancer risk in BRCA1 mutation carriers.

Colilla S, Kantoff PW, Neuhausen SL, Godwin AK, Daly MB, Narod SA, Garber JE, Lynch HT, Brown M, Weber BL, Rebbeck TR.

Carcinogenesis. 2006 Mar;27(3):599-605. Epub 2005 Oct 22.


The tumor spectrum in the Lynch syndrome.

Watson P, Riley B.

Fam Cancer. 2005;4(3):245-8. Review.


Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset.

Hampel H, Stephens JA, Pukkala E, Sankila R, Aaltonen LA, Mecklin JP, de la Chapelle A.

Gastroenterology. 2005 Aug;129(2):415-21.


A weighted cohort approach for analysing factors modifying disease risks in carriers of high-risk susceptibility genes.

Antoniou AC, Goldgar DE, Andrieu N, Chang-Claude J, Brohet R, Rookus MA, Easton DF.

Genet Epidemiol. 2005 Jul;29(1):1-11.


Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X.

Lindor NM, Rabe K, Petersen GM, Haile R, Casey G, Baron J, Gallinger S, Bapat B, Aronson M, Hopper J, Jass J, LeMarchand L, Grove J, Potter J, Newcomb P, Terdiman JP, Conrad P, Moslein G, Goldberg R, Ziogas A, Anton-Culver H, de Andrade M, Siegmund K, Thibodeau SN, Boardman LA, Seminara D.

JAMA. 2005 Apr 27;293(16):1979-85.


Tobacco use and increased colorectal cancer risk in patients with hereditary nonpolyposis colorectal cancer (Lynch syndrome).

Watson P, Ashwathnarayan R, Lynch HT, Roy HK.

Arch Intern Med. 2004 Dec 13-27;164(22):2429-31.


Tobacco smoking and cancer: a brief review of recent epidemiological evidence.

Sasco AJ, Secretan MB, Straif K.

Lung Cancer. 2004 Aug;45 Suppl 2:S3-9. Review.


BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing.

Domingo E, Laiho P, Ollikainen M, Pinto M, Wang L, French AJ, Westra J, Frebourg T, Espín E, Armengol M, Hamelin R, Yamamoto H, Hofstra RM, Seruca R, Lindblom A, Peltomäki P, Thibodeau SN, Aaltonen LA, Schwartz S Jr.

J Med Genet. 2004 Sep;41(9):664-8.


Smoking and the risk of breast cancer among carriers of BRCA mutations.

Ghadirian P, Lubinski J, Lynch H, Neuhausen SL, Weber B, Isaacs C, Baruch RG, Randall S, Ainsworth P, Friedman E, Horsman D, Tonin P, Foulkes WD, Tung N, Sun P, Narod SA.

Int J Cancer. 2004 Jun 20;110(3):413-6. Erratum in: Int J Cancer. 2005 May 10;114(6):1016. Freidman, Eitan [corrected to Friedman, Eitan].


BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer.

Deng G, Bell I, Crawley S, Gum J, Terdiman JP, Allen BA, Truta B, Sleisenger MH, Kim YS.

Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):191-5.

Items per page

Supplemental Content

Write to the Help Desk